• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Paul Capital

edit

Paul Capital was formed in 1991 as a pioneer in the secondary market, providing creative liquidity solutions to investors in private equity limited partnerships and portfolios of direct investments. In 1999, Paul Capital added its Healthcare Platform to invest in royalty and revenue interests in life science products. Today, Paul Capital sees the world from the vantage point of an experienced investor with unique insight and the ability to build compelling solutions for institutional investors. The team has grown to nearly 100 employees, with offices in Hong Kong, London, New York, Paris, San Francisco and São Paulo, managing a total of more than $6 billion across its distinct investment platforms.

Recent Milestones

edit

• 
  Paul Capital invested in Recyclebank. (2/22/11)
  Posted 2/23/11 at 7:51pm via recyclebank.com
• 
  Paul Capital invested in Phase III Development. (1/5/10)
  Posted 1/7/10 at 1:15am via pehub.com
• 
  Paul Capital invested in UCB Pharma. (12/22/09)
  Posted 12/23/09 at 1:55am via dowjones.com
• 
  Paul Capital invested in SpePharm. (8/21/08)
  Posted 6/22/09 at 1:29am via spepharm.com

Investments

Videos

Sources

1. Recyclebank Raises Additional $14 Million in Series C Financing (recyclebank.com) [edit]
2. P3D Raises $100 Million from Paul Capital (pehub.com) [edit]
3. Paul Capital Invests $100M In Belgian Pharma UCB In Royalty Deal (fis.dowjones.com) [edit]
4. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare enter into €26 Million Financing of SpePharm (spepharm.com) [edit]